Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanjun Wen

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
The Protein Journal|May 17, 2011
Proteomic analyses of gastric cancer cells treated with vesicular stomatitis virus matrix proteinDequan Zeng, Tao Zhang, Shengtao Zhou, et al.
Biochemical and Biophysical Research Communications|August 30, 2008
Immunotherapy of hepatocellular carcinoma with a vaccine based on xenogeneic homologous alpha fetoprotein in miceWei Zhang, Jiyan Liu, Yang Wu, et al.
Advances in Colloid and Interface Science|June 10, 2023
The bioavailability, metabolism and microbial modulation of curcumin-loaded nanodelivery systemsRuxin Chang, Liran Chen, Muhammad Qamar, et al.
International Journal of Molecular Medicine|June 20, 2012
Local delivery of recombinant adenovirus expressing hepatitis B virus X protein and interleukin-12 results in antitumor effects via inhibition of hepatoma cell growth and intervention of tumor microenvironmentHong He, Ping Fan, Tao Yin, et al.
Cancer Biology & Therapy|December 15, 2010
Intravenous liposomal delivery of the short hairpin RNAs against Plk1 controls the growth of established human hepatocellular carcinomaHongxin Deng, Qingyuan Jiang, Yang Yang, et al.
British Journal of Cancer|August 9, 2017
miR-29a/b/c function as invasion suppressors for gliomas by targeting CDC42 and predict the prognosis of patientsCuijuan Shi, Linlin Ren, Cuiyun Sun, et al.
Oncotarget|February 5, 2017
miR-320a functions as a suppressor for gliomas by targeting SND1 and β-catenin, and predicts the prognosis of patientsHuining Li, Lin Yu, Jing Liu, et al.
Neuroscience Letters|January 28, 2015
miR-29s inhibit the malignant behavior of U87MG glioblastoma cell line by targeting DNMT3A and 3BHui Xu, Jing Sun, Cuijuan Shi, et al.
Oncology Reports|November 15, 2011
Diluted povidone-iodine inhibits tumor growth through apoptosis-induction and suppression of SOD activityPing Sun, Ju-Mei Zhao, Zi-Chao Luo, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 20, 2005
Active antitumor immunity elicited by vaccine based on recombinant form of epidermal growth factor receptorBing Hu, Yuquan Wei, Ling Tian, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
The Protein Journal|May 17, 2011
Proteomic analyses of gastric cancer cells treated with vesicular stomatitis virus matrix proteinDequan Zeng, Tao Zhang, Shengtao Zhou, et al.
Biochemical and Biophysical Research Communications|August 30, 2008
Immunotherapy of hepatocellular carcinoma with a vaccine based on xenogeneic homologous alpha fetoprotein in miceWei Zhang, Jiyan Liu, Yang Wu, et al.
Advances in Colloid and Interface Science|June 10, 2023
The bioavailability, metabolism and microbial modulation of curcumin-loaded nanodelivery systemsRuxin Chang, Liran Chen, Muhammad Qamar, et al.
International Journal of Molecular Medicine|June 20, 2012
Local delivery of recombinant adenovirus expressing hepatitis B virus X protein and interleukin-12 results in antitumor effects via inhibition of hepatoma cell growth and intervention of tumor microenvironmentHong He, Ping Fan, Tao Yin, et al.
Cancer Biology & Therapy|December 15, 2010
Intravenous liposomal delivery of the short hairpin RNAs against Plk1 controls the growth of established human hepatocellular carcinomaHongxin Deng, Qingyuan Jiang, Yang Yang, et al.
British Journal of Cancer|August 9, 2017
miR-29a/b/c function as invasion suppressors for gliomas by targeting CDC42 and predict the prognosis of patientsCuijuan Shi, Linlin Ren, Cuiyun Sun, et al.
Oncotarget|February 5, 2017
miR-320a functions as a suppressor for gliomas by targeting SND1 and β-catenin, and predicts the prognosis of patientsHuining Li, Lin Yu, Jing Liu, et al.
Neuroscience Letters|January 28, 2015
miR-29s inhibit the malignant behavior of U87MG glioblastoma cell line by targeting DNMT3A and 3BHui Xu, Jing Sun, Cuijuan Shi, et al.
Oncology Reports|November 15, 2011
Diluted povidone-iodine inhibits tumor growth through apoptosis-induction and suppression of SOD activityPing Sun, Ju-Mei Zhao, Zi-Chao Luo, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 20, 2005
Active antitumor immunity elicited by vaccine based on recombinant form of epidermal growth factor receptorBing Hu, Yuquan Wei, Ling Tian, et al.
Pageof 7